Tuesday, January 07, 2025 | 10:29 PM ISTEN Hindi
The drug firm, however, did not provide any details of the contents of the warning letter received from the regulator.
The product will be manufactured at Strides' facility in Bengaluru and will be marketed by Strides Pharma in the US market